由 junii B6 型不动杆菌产生的脂肽生物表面活性剂可减轻大鼠哮喘引起的肺部炎症、氧化和组织病理学改变

IF 2 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY International Journal of Peptide Research and Therapeutics Pub Date : 2024-01-08 DOI:10.1007/s10989-024-10586-x
Mohammad Abbas Bejeshk, Mohammad Amin Rajizadeh, Abolfazl Yari, Fatemeh Bagheri, Hamid Najafipour, Gholamreza Dehghannoudeh, Niyan Salehi, Mehrnaz Mehrabani, Mandana Ohadi, Amir Hashem Aminizadeh
{"title":"由 junii B6 型不动杆菌产生的脂肽生物表面活性剂可减轻大鼠哮喘引起的肺部炎症、氧化和组织病理学改变","authors":"Mohammad Abbas Bejeshk, Mohammad Amin Rajizadeh, Abolfazl Yari, Fatemeh Bagheri, Hamid Najafipour, Gholamreza Dehghannoudeh, Niyan Salehi, Mehrnaz Mehrabani, Mandana Ohadi, Amir Hashem Aminizadeh","doi":"10.1007/s10989-024-10586-x","DOIUrl":null,"url":null,"abstract":"<p>The two main characteristics of asthma pathogenesis are severe inflammation and excessive oxidative stress production. Biosurfactant (BS), as surface-active metabolites synthesized by microorganisms, is mainly isolated from bacterial strains and was previously reported to have various therapeutic functions, such as providing antioxidant and anti-inflammatory benefits. Our study aimed to investigate the anti-inflammatory and anti-oxidative role of lipopeptide BS using an experimental asthma model in rats. Lipopeptide BS was isolated from <i>Acinetobacter junii</i> B6. In vivo, male rats were randomly assigned into four groups (7 rats in each group); normal control rats (CTL), non-treated asthmatic rats, asthmatic rats received BS, and asthmatic rats treated with budesonide (positive control). Administration of ovalbumin (OVA) to rats was used to induce an allergic asthma model. At the end of the induction period, the ELISA method was used to determine the inflammatory and OS markers in BALF and lung tissue. Moreover, total protein and IgE concentrations were determined in lung tissue, BALF, and serum, respectively. A histological study of lung tissue was performed using H&amp;E staining. Treatment with Lipopeptide BS decreased inflammatory cell count in lung tissue and also reduced the level of cytokines and oxidant parameters (TNF-α, IL-1β, IL-6 and MDA, total protein, nitrite) in both BALF and lung tissue. Also, the IgE level in serum was reduced by Lipopeptide BS administration. In contrast, the level of IL-10, TAC level, SOD, and GPX activity was elevated in both BALF and lung tissue following Lipopeptide BS administration. The histological evaluation indicated that Lipopeptide BS considerably inhibited histopathological changes, airway and epithelial damage, emphysema, and goblet cell hyperplasia in the tissue.</p><p>The preventive effect of Lipopeptide BS is potentially promising in asthma treatment through reducing histological changes, inflammation, and oxidative stress.</p>","PeriodicalId":14217,"journal":{"name":"International Journal of Peptide Research and Therapeutics","volume":"50 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lipopeptide Biosurfactant Produced by Acinetobacter junii B6 Attenuates Lung Inflammatory, Oxidative, and Histopathological Alterations due to Asthma in Rats\",\"authors\":\"Mohammad Abbas Bejeshk, Mohammad Amin Rajizadeh, Abolfazl Yari, Fatemeh Bagheri, Hamid Najafipour, Gholamreza Dehghannoudeh, Niyan Salehi, Mehrnaz Mehrabani, Mandana Ohadi, Amir Hashem Aminizadeh\",\"doi\":\"10.1007/s10989-024-10586-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The two main characteristics of asthma pathogenesis are severe inflammation and excessive oxidative stress production. Biosurfactant (BS), as surface-active metabolites synthesized by microorganisms, is mainly isolated from bacterial strains and was previously reported to have various therapeutic functions, such as providing antioxidant and anti-inflammatory benefits. Our study aimed to investigate the anti-inflammatory and anti-oxidative role of lipopeptide BS using an experimental asthma model in rats. Lipopeptide BS was isolated from <i>Acinetobacter junii</i> B6. In vivo, male rats were randomly assigned into four groups (7 rats in each group); normal control rats (CTL), non-treated asthmatic rats, asthmatic rats received BS, and asthmatic rats treated with budesonide (positive control). Administration of ovalbumin (OVA) to rats was used to induce an allergic asthma model. At the end of the induction period, the ELISA method was used to determine the inflammatory and OS markers in BALF and lung tissue. Moreover, total protein and IgE concentrations were determined in lung tissue, BALF, and serum, respectively. A histological study of lung tissue was performed using H&amp;E staining. Treatment with Lipopeptide BS decreased inflammatory cell count in lung tissue and also reduced the level of cytokines and oxidant parameters (TNF-α, IL-1β, IL-6 and MDA, total protein, nitrite) in both BALF and lung tissue. Also, the IgE level in serum was reduced by Lipopeptide BS administration. In contrast, the level of IL-10, TAC level, SOD, and GPX activity was elevated in both BALF and lung tissue following Lipopeptide BS administration. The histological evaluation indicated that Lipopeptide BS considerably inhibited histopathological changes, airway and epithelial damage, emphysema, and goblet cell hyperplasia in the tissue.</p><p>The preventive effect of Lipopeptide BS is potentially promising in asthma treatment through reducing histological changes, inflammation, and oxidative stress.</p>\",\"PeriodicalId\":14217,\"journal\":{\"name\":\"International Journal of Peptide Research and Therapeutics\",\"volume\":\"50 1\",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-01-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Peptide Research and Therapeutics\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1007/s10989-024-10586-x\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Peptide Research and Therapeutics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s10989-024-10586-x","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

哮喘发病的两个主要特征是严重的炎症反应和过度的氧化应激反应。生物表面活性剂(BS)是由微生物合成的表面活性代谢物,主要从细菌菌株中分离出来,据报道具有多种治疗功能,如抗氧化和抗炎。我们的研究旨在利用大鼠实验性哮喘模型研究脂肽 BS 的抗炎和抗氧化作用。脂肽 BS 从 junii B6 型不动杆菌中分离出来。将雄性大鼠随机分为四组(每组 7 只):正常对照组(CTL)、未接受治疗的哮喘大鼠、接受 BS 治疗的哮喘大鼠和接受布地奈德治疗的哮喘大鼠(阳性对照组)。给大鼠注射卵清蛋白(OVA)诱导过敏性哮喘模型。诱导期结束后,采用 ELISA 方法测定 BALF 和肺组织中的炎症和 OS 标志物。此外,还分别测定了肺组织、BALF 和血清中的总蛋白和 IgE 浓度。使用 H&E 染色法对肺组织进行了组织学研究。经脂肽 BS 治疗后,肺组织中的炎症细胞数量减少,BALF 和肺组织中的细胞因子和氧化参数(TNF-α、IL-1β、IL-6 和 MDA、总蛋白、亚硝酸盐)水平也降低。此外,血清中的 IgE 水平也因服用脂肽 BS 而降低。相反,服用脂肽 BS 后,BALF 和肺组织中的 IL-10 水平、TAC 水平、SOD 和 GPX 活性均升高。组织学评估表明,脂肽 BS 可显著抑制组织病理学变化、气道和上皮损伤、肺气肿和组织中的上皮细胞增生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Lipopeptide Biosurfactant Produced by Acinetobacter junii B6 Attenuates Lung Inflammatory, Oxidative, and Histopathological Alterations due to Asthma in Rats

The two main characteristics of asthma pathogenesis are severe inflammation and excessive oxidative stress production. Biosurfactant (BS), as surface-active metabolites synthesized by microorganisms, is mainly isolated from bacterial strains and was previously reported to have various therapeutic functions, such as providing antioxidant and anti-inflammatory benefits. Our study aimed to investigate the anti-inflammatory and anti-oxidative role of lipopeptide BS using an experimental asthma model in rats. Lipopeptide BS was isolated from Acinetobacter junii B6. In vivo, male rats were randomly assigned into four groups (7 rats in each group); normal control rats (CTL), non-treated asthmatic rats, asthmatic rats received BS, and asthmatic rats treated with budesonide (positive control). Administration of ovalbumin (OVA) to rats was used to induce an allergic asthma model. At the end of the induction period, the ELISA method was used to determine the inflammatory and OS markers in BALF and lung tissue. Moreover, total protein and IgE concentrations were determined in lung tissue, BALF, and serum, respectively. A histological study of lung tissue was performed using H&E staining. Treatment with Lipopeptide BS decreased inflammatory cell count in lung tissue and also reduced the level of cytokines and oxidant parameters (TNF-α, IL-1β, IL-6 and MDA, total protein, nitrite) in both BALF and lung tissue. Also, the IgE level in serum was reduced by Lipopeptide BS administration. In contrast, the level of IL-10, TAC level, SOD, and GPX activity was elevated in both BALF and lung tissue following Lipopeptide BS administration. The histological evaluation indicated that Lipopeptide BS considerably inhibited histopathological changes, airway and epithelial damage, emphysema, and goblet cell hyperplasia in the tissue.

The preventive effect of Lipopeptide BS is potentially promising in asthma treatment through reducing histological changes, inflammation, and oxidative stress.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.50
自引率
8.00%
发文量
131
审稿时长
>12 weeks
期刊介绍: The International Journal for Peptide Research & Therapeutics is an international, peer-reviewed journal focusing on issues, research, and integration of knowledge on the latest developments in peptide therapeutics. The Journal brings together in a single source the most exciting work in peptide research, including isolation, structural characterization, synthesis and biological activity of peptides, and thereby aids in the development of unifying concepts from diverse perspectives. The Journal invites substantial contributions in the following thematic areas: -New advances in peptide drug delivery systems. -Application of peptide therapeutics to specific diseases. -New advances in synthetic methods. -The development of new procedures for construction of peptide libraries and methodology for screening of such mixtures. -The use of peptides in the study of enzyme specificity and mechanism, receptor binding and antibody/antigen interactions -Applications of such techniques as chromatography, electrophoresis, NMR and X-ray crystallography, mass spectrometry.
期刊最新文献
Synthetic studies of the mutant proinsulin syndrome demonstrate correlation between folding efficiency and age of diabetes onset. Isolation of Peptide Ligands for the HIV Capsid Protein p24 by Phage-Display. Molecular Chimera in Cancer Drug Discovery: Beyond Antibody Therapy, Designing Grafted Stable Peptides Targeting Cancer. Synthetic Short Cryptic Antimicrobial Peptides as Templates for the Development of Novel Biotherapeutics Against WHO Priority Pathogen Molecular Mechanism of NL13 Peptide of Adenosyl Homocysteinase Against ER Stress through Nrf2 Signaling Cascade
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1